胆固醇,血脂和动脉硬化。

Ian Wilkinson, John R Cockcroft
{"title":"胆固醇,血脂和动脉硬化。","authors":"Ian Wilkinson,&nbsp;John R Cockcroft","doi":"10.1159/000096747","DOIUrl":null,"url":null,"abstract":"<p><p>Arterial stiffness and pulse pressure are important determinants of cardiovascular risk. Patients with hypercholesterolaemia have a higher central pulse pressure and stiffer blood vessels than matched controls, despite similar peripheral blood pressures. These haemodynamic changes may contribute to the increased risk of cardiovascular disease associated with hypercholesterolaemia and their assessment may improve risk stratification. Lipid-lowering therapy, particularly with statins, generally leads to a reduction in arterial stiffness, re-enforcing the concept that stiffness is a modifiable parameter and risk factor. There are a number of potential mechanisms linking arterial stiffness and plasma lipids, including atherosclerosis, changes in the elastic elements of the arterial wall, endothelial dysfunction and inflammation. This review will focus on the current evidence linking cholesterol to larger artery stiffening, potential therapies and mechanisms.</p>","PeriodicalId":50954,"journal":{"name":"Advances in Cardiology","volume":"44 ","pages":"261-277"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000096747","citationCount":"88","resultStr":"{\"title\":\"Cholesterol, lipids and arterial stiffness.\",\"authors\":\"Ian Wilkinson,&nbsp;John R Cockcroft\",\"doi\":\"10.1159/000096747\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Arterial stiffness and pulse pressure are important determinants of cardiovascular risk. Patients with hypercholesterolaemia have a higher central pulse pressure and stiffer blood vessels than matched controls, despite similar peripheral blood pressures. These haemodynamic changes may contribute to the increased risk of cardiovascular disease associated with hypercholesterolaemia and their assessment may improve risk stratification. Lipid-lowering therapy, particularly with statins, generally leads to a reduction in arterial stiffness, re-enforcing the concept that stiffness is a modifiable parameter and risk factor. There are a number of potential mechanisms linking arterial stiffness and plasma lipids, including atherosclerosis, changes in the elastic elements of the arterial wall, endothelial dysfunction and inflammation. This review will focus on the current evidence linking cholesterol to larger artery stiffening, potential therapies and mechanisms.</p>\",\"PeriodicalId\":50954,\"journal\":{\"name\":\"Advances in Cardiology\",\"volume\":\"44 \",\"pages\":\"261-277\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000096747\",\"citationCount\":\"88\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000096747\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000096747","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 88

摘要

动脉僵硬度和脉压是心血管风险的重要决定因素。与对照组相比,高胆固醇血症患者的中心脉压更高,血管更僵硬,尽管外周血压相似。这些血流动力学变化可能导致与高胆固醇血症相关的心血管疾病的风险增加,其评估可能改善风险分层。降脂治疗,特别是他汀类药物,通常会导致动脉僵硬度的降低,这强化了僵硬度是一个可改变的参数和危险因素的概念。有许多潜在的机制将动脉硬化和血脂联系起来,包括动脉粥样硬化、动脉壁弹性成分的改变、内皮功能障碍和炎症。这篇综述将集中在目前的证据链接胆固醇与大动脉硬化,潜在的治疗和机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cholesterol, lipids and arterial stiffness.

Arterial stiffness and pulse pressure are important determinants of cardiovascular risk. Patients with hypercholesterolaemia have a higher central pulse pressure and stiffer blood vessels than matched controls, despite similar peripheral blood pressures. These haemodynamic changes may contribute to the increased risk of cardiovascular disease associated with hypercholesterolaemia and their assessment may improve risk stratification. Lipid-lowering therapy, particularly with statins, generally leads to a reduction in arterial stiffness, re-enforcing the concept that stiffness is a modifiable parameter and risk factor. There are a number of potential mechanisms linking arterial stiffness and plasma lipids, including atherosclerosis, changes in the elastic elements of the arterial wall, endothelial dysfunction and inflammation. This review will focus on the current evidence linking cholesterol to larger artery stiffening, potential therapies and mechanisms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信